SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000950137-05-003891
Filing Date
2005-03-30
Accepted
2005-03-30 16:22:02
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-KSB c93674e10ksb.htm 10KSB 630062
2 EMPLOYMENT AGREEMENT, DATED JANUARY 21, 1998 c93674exv10w10.htm EX-10.10 65382
3 DESCRIPTION OF NON-EMPLOYEE DIRECTOR COMPENSATION ARRANGEMENTS c93674exv10w35.htm EX-10.35 1555
4 DESCRIPTION OF EXECUTIVE OFFICER COMPENSATION ARRANGMENTS c93674exv10w36.htm EX-10.36 14030
5 CONSENT OF DELOITTE & TOUCHE LLP c93674exv23w1.htm EX-23.1 1530
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER TO RULE 13A-14 c93674exv31w1.htm EX-31.1 5976
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER TO RULE 13A-14 c93674exv31w2.htm EX-31.2 6302
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER TO SECTION 906 c93674exv32w1.htm EX-32.1 3176
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER TO SECTION 906 c93674exv32w2.htm EX-32.2 2576
  Complete submission text file 0000950137-05-003891.txt   733473
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 001-31812 | Film No.: 05714519
SIC: 2836 Biological Products, (No Diagnostic Substances)